Change search criteria ↓

Search results

86 projects found matching your search criteria:

  1. 1. Chemical effects in targeted drug delivery: The roles of anticancer drugs, carriers and conjugates on biomimetic membran…

    Principal investigator: dr Dorota Maria Nieciecka

    Uniwersytet Warszawski, Wydział Chemii

    Call: SONATA 12, Panel: ST4

  2. 2. Exploring new drug targets for efficacious therapy of neuropathic pain basing on the assessment and modulation of neuroi…

    Principal investigator: dr hab. Joanna Gabriela Mika

    Instytut Farmakologii PAN

    Call: OPUS 2, Panel: NZ4

  3. 3. Hyphenated separation techniques in the study of the molecular mechanisms of metabolic biotransformation of drugs for ta…

    Principal investigator: dr Małgorzata Szultka-Młyńska

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

    Call: SONATA 12, Panel: ST4

  4. 4. Functional nanomaterials based on drug–lipid–ligands as targeted delivery systems for anticancer agents in lung adenocar…

    Principal investigator: Piotr Paweł Szyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 24, Panel: NZ7

  5. 5. Stimuli-responsive anion transporters for targeted drug delivery

    Principal investigator: dr hab. Michał Jan Chmielewski

    Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

    Call: OPUS 26, Panel: ST5

  6. 6. Parallel quantitative evaluation of targetability, cellular uptake, and intracellular drug release for the establishment…

    Principal investigator: prof. Adolfo Rivero Müller

    Uniwersytet Medyczny w Lublinie, Wydział Nauk Medycznych

    Call: OPUS 20 (LAP), Panel: ST5

  7. 7. Dual-targeted biodegradable polymeric micelles for anticancer drug delivery

    Principal investigator: dr Katarzyna Jelonek

    Centrum Materiałów Polimerowych i Węglowych PAN

    Call: SONATA BIS 9, Panel: NZ7

  8. 8. Novel core-shell micro-sized systems for macrophage-targeted drug delivery via phagocytosis

    Principal investigator: dr Tomasz Marek Urbaniak

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: PRELUDIUM 17, Panel: NZ7

  9. 9. The enzymes of RNA metabolism, PAP I and PNPase, as targets for new antimycobacterial drugs and their functional charact…

    Principal investigator: prof. Jarosław Dziadek

    Instytut Biologii Medycznej PAN

    Call: OPUS 13, Panel: NZ7

  10. 10. Supramolecular compounds and their complexes with carbon nanotubes as potential systems for targeted delivery of drugs

    Principal investigator: dr Anna Jagusiak

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: SONATA 11, Panel: NZ1

  11. 11. Targeted drug delivery systems - synthesis and functionalization of nanocarriers

    Principal investigator: dr Krzysztof Szczepanowicz

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

    Call: SONATA 2, Panel: ST5

  12. 12. Identification and targeting molecular drug resistance mechanisms in adult B-cell acute lymphoblastic leukemia

    Principal investigator: dr hab. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

    Call: OPUS 1, Panel: NZ4

  13. 13. New drug carriers in targeted anticancer therapy

    Principal investigator: prof. Artur Piotr Terzyk

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

    Call: OPUS 1, Panel: ST5

  14. 14. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno…

    Principal investigator: Anna Karolina Pogorzelska

    Narodowy Instytut Leków

    Call: PRELUDIUM 20, Panel: NZ7

  15. 15. Drug repurposing to target p53 protein family for improved therapy in the relapsed TP53 and EGFR mutated lung cancer

    Principal investigator: dr hab. Alicja Elżbieta Chrzanowska

    Warszawski Uniwersytet Medyczny

    Call: OPUS 20, Panel: NZ7

  16. 16. Lactoferrin and versatile polymers as a tool for selective and targeted delivery of anticancer hydrophobic drugs in the …

    Principal investigator: Przemysław Krzysztof Gajda-Morszewski

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 18, Panel: NZ7

  17. 17. Integrated multi-omics approach to accelerate anticancer drug discovery by targeting metabolic reprogramming in human co…

    Principal investigator: dr hab. Danuta Dudzik

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 26, Panel: NZ7

  18. 18. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p…

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM BIS 4, Panel: NZ7

  19. 19. Synthetic epidermal growth factor receptor inhibitor conjugated with nobel metal nanoparticles as a potential drug for t…

    Principal investigator: Shaoshan Mai

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: PRELUDIUM 20, Panel: NZ7

  20. 20. New multifunctional drug-like ligands focusing on molecular targets associated with the symptoms and causes of Alzheimer…

    Principal investigator: Anna Marta Pasieka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 19, Panel: NZ7

  21. 21. Exosome biosensors - new tools in cancer screening, diagnostics and development of targeted drug delivery system

    Principal investigator: dr hab. Magdalena Stobiecka

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

    Call: OPUS 13, Panel: ST4

  22. 22. Efficacy, toxicity and immunogenicity of carriers made of bioengineered spider silk for targeted drug delivery

    Principal investigator: dr hab. Hanna Dams-Kozłowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

    Call: OPUS 8, Panel: NZ7

  23. 23. Hydrogel microspheres containing dextran-based nanoparticles. Study on targeting effect in novel anticancer drug deliver…

    Principal investigator: Aleksandra Anna Kulikowska

    Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

    Call: PRELUDIUM 7, Panel: NZ5

  24. 24. Characteristics of neuropilin-1 (NRP1) as a target of antiangiogenic activity of immunomodulatory drugs in multiple myel…

    Principal investigator: prof. Krzysztof Giannopoulos

    Uniwersytet Medyczny w Lublinie, II Wydział Lekarski z Oddziałem Anglojęzycznym

    Call: OPUS 7, Panel: NZ6

  25. 25. Physicochemical characterization of cyclodextrins tailored for pH-dependent targeted therapy with anthracycline drugs

    Principal investigator: prof. Renata Bilewicz

    Uniwersytet Warszawski, Wydział Chemii

    Call: OPUS 7, Panel: ST5

  26. 26. The group III metabotropic glutamate receptors as a target for future antypsychotic drugs

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii PAN

    Call: MAESTRO 3, Panel: NZ7

  27. 27. Evaluating the antibacterial activity of the bacteriophage protein targeting Staphylococcus aureus, including drug-resis…

    Principal investigator: dr Zuzanna Maria Kaźmierczak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: SONATA 19, Panel: NZ7

  28. 28. Deciphering the Chemoproteomics and Chemotranscriptomics of Anti-Alzheimer Drugs for Novel Druggable Target Identificati…

    Principal investigator: prof. Krzysztof Sobczak

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: JPND Call 2023, Panel: NZ5

  29. 29. Curdlan-based biomaterial as a nanostructure carrier for controlled and targeted drug delivery in the treatment of deep …

    Principal investigator: dr Aleksandra Nurzyńska

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 22, Panel: NZ7

  30. 30. Conjugates of peptide nucleic acids with aminoglycosides and fluoroquinolones as a novel strategy to target multi-drug r…

    Principal investigator: Izabela Siekierska

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: PRELUDIUM 22, Panel: ST5

  31. 31. Targeting a unique mRNA decapping enzyme for trypanosomatid infectious disease drug discovery, chemical biology and biot…

    Principal investigator: dr Maria Wiktoria Górna

    Uniwersytet Warszawski, Wydział Chemii

    Call: WEAVE-UNISONO, Panel: NZ1

  32. 32. Homo- and heterometallic phosphine ruthenium and iridium complexes - design, synthesis, bioactivity and magnetic-nanofor…

    Principal investigator: Sandra Amanda Kozieł

    Uniwersytet Wrocławski, Wydział Chemii

    Call: PRELUDIUM 19, Panel: ST4

  33. 33. Novel L-asparaginases as potential therapeutic agents and antimicrobial targets: structural and functional studies of en…

    Principal investigator: prof. Mariusz Jaskólski

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 19, Panel: NZ1

  34. 34. Atomization of liquids for targeted drug delivery to the respiratory system - mechanisms of droplets formation, transpor…

    Principal investigator: prof. Tomasz Robert Sosnowski

    Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

    Call: OPUS 15, Panel: ST8

  35. 35. Determination of arginase-1 as a potential drug target in the treatment of multiple myeloma and in reducing proteasome i…

    Principal investigator: prof. Jakub Adam Gołąb

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 13, Panel: NZ6

  36. 36. Inteligent oligosilsesquioxane nanoconjugates of anticancer drugs with targeting moieties.

    Principal investigator: Kinga Piórecka

    Centrum Badań Molekularnych i Makromolekularnych PAN

    Call: PRELUDIUM 11, Panel: ST5

  37. 37. Synthesis and biological evaluation of novel, drug-like multifunctional ligands, as potential anti-Alzheimer's agents ta…

    Principal investigator: Dawid Marcin Panek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 11, Panel: NZ7

  38. 38. Investigation of meluclar mechanism of new cell-based, targeted delivery method of anticancer drugs to the tumour tissue

    Principal investigator: dr hab. Magdalena Król

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Wydział Medycyny Weterynaryjnej

    Call: SONATA BIS 5, Panel: NZ6

  39. 39. A coarse-grained model of protein - nanoparticles interactions for simulating the transport of drug molecules to their t…

    Principal investigator: dr Magdalena Anna Mozolewska

    Uniwersytet Gdański, Wydział Chemii

    Call: PRELUDIUM 9, Panel: ST4

  40. 40. Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate releas…

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ7

  41. 41. Mitochondrial aldehyde dehydrogenase (ALDH2) as a new target for anti-atherosclerotic drugs

    Principal investigator: Aneta Olga Stachowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: PRELUDIUM 1, Panel: NZ4

  42. 42. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res…

    Principal investigator: dr hab. Mariusz Łukasz Hartman

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 25, Panel: NZ5

  43. 43. Novel broad-spectrum central nervous system active substances: optimization of their multi-target profile

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: OPUS 22, Panel: NZ7

  44. 44. Polymer-based nanostructures modified with biologically active substances for selective accumulation and release of drug…

    Principal investigator: Wioletta Sylwia Liwińska

    Uniwersytet Warszawski, Wydział Chemii

    Call: PRELUDIUM 10, Panel: ST5

  45. 45. Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinocice…

    Principal investigator: dr Michał Andrzej Abram

    Uniwersytet Jagielloński

    Call: OPUS 29, Panel: NZ7

  46. 46. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

    Principal investigator: dr Michał Jerzy Woźniak

    Uniwersytet Medyczny w Łodzi

    Call: OPUS 28, Panel: NZ7

  47. 47. A Compound Screening Platform for the Discovery of Histone- and Nucleosome-Targeting Agents

    Principal investigator: prof. Curtis Davey

    Uniwersytet Jagielloński

    Call: OPUS 27, Panel: NZ7

  48. 48. Bacterial membrane carriers targeting tumor-associated microbes for advanced cancer therapy

    Principal investigator: dr Monika Kluzek

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: OPUS 26, Panel: NZ7

  49. 49. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

    Principal investigator: dr Urszula Helena Piotrowska

    Warszawski Uniwersytet Medyczny

    Call: SONATA 18, Panel: NZ7

  50. 50. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: SONATA 17, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski